Hisse Senetlerindeki Sıralama
#33866
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Hisse Fiyatı
$0.5475
Son senkronizasyon: 2026-08-14
Ticaret 20/20 Biolabs Inc. (AIDX)
B piyasa değeri ile AIDX fiyatı
Piyasa Değeri 20/20 Biolabs Inc.(AIDX)
Piyasa Değeri: $6.71M
August 2026 itibarıyla 20/20 Biolabs Inc. şirketinin piyasa değeri $6.71M. Bu, verilerimize göre 20/20 Biolabs Inc. şirketini dünyanın en değerli 33866th. şirketi yapar. Piyasa değeri, halka açık bir şirketin tedavüldeki hisse senetlerinin toplam piyasa değeri olup, bir şirketin değerini ölçmek için yaygın olarak kullanılır.
20/20 Biolabs Inc. piyasa değeri geçmişi (2026 - 2026)
En Popüler 5 stocks ile karşılaştırıldığında AIDX
| AIDX’in Fiyatı |
|
B Varlığı |
B’nin Piyasa Değeri |
Sonuçlar |
|
|
|
|
$5.452T
|
+81,276,656.64%
|
|
|
|
|
$4.490T
|
+66,937,378.02%
|
|
|
|
|
$4.162T
|
+62,053,302.40%
|
|
|
|
|
$3.676T
|
+54,807,023.79%
|
|
|
|
|
$2.833T
|
+42,235,061.84%
|
